Dual antiplatelet therapy with aspirin and clopidogrel is currently the standard therapy after
coronary stent implantation to prevent a life-threatening stent thrombosis. However, a variety …

Inhibition of platelet activation is a cornerstone of adjunctive medical treatment during and
after percutaneous coronary interventions with stent implantation (PCI-S) in order to prevent …

Antiplatelet therapy with aspirin and clopidogrel is standard care following revascularization
by percutaneous coronary intervention with stent insertion. This so-called dual therapy is …

Background An increasing number of patients undergoing coronary stenting need lifelong
anticoagulation and therefore require a triple therapy typically consisting of aspirin …

Antiplatelet therapy is key to reducing local thrombotic complications and systemic
ischaemic events among patients undergoing percutaneous coronary interventions (PCI) …

Antiplatelet therapy is the cornerstone for both primary and secondary prevention therapies
for ischemic events resulting from coronary atherosclerotic disease. Dual antiplatelet therapy …

In patients undergoing coronary stenting, long-term dual antiplatelet therapy with aspirin and
clopidogrel reduces atherothrombotic events but also increases the risk of bleeding. The …

Objectives: We evaluated safety and efficacy of triple antiplatelet therapy with aspirin,
clopidogrel, or ticlopidine and cilostazol after coronary stenting. Background: Triple …

Percutaneous coronary intervention (PCI) has become a standard-of-care procedure in the
setting of angina or acute coronary syndrome. Antithrombotic therapy is the cornerstone of …

Prolonged dual antiplatelet therapy with aspirin and clopidogrel is mandatory after drug-
eluting stent (DES) implantation because of potential increase risk of stent thrombosis …